These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6894853)

  • 1. Characterization of Langerhans' cells using a monoclonal anti-HLA-DR (Ia-like) antibody.
    Cohen JH; Bouveret E; Pluot M; Revillard JP
    Arch Pathol Lab Med; 1981 Aug; 105(8):438. PubMed ID: 6894853
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.
    Hussain LA; Lehner T
    Immunology; 1995 Jul; 85(3):475-84. PubMed ID: 7558138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Langerhans' cells and identification with antibodies.
    Murphy GF; Harrist TJ
    Arch Pathol Lab Med; 1982 May; 106(5):255-6. PubMed ID: 6951506
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes.
    Ma J; Wang JH; Guo YJ; Sy MS; Bigby M
    Cell Immunol; 1994 Oct; 158(2):389-99. PubMed ID: 7923390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
    Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
    J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical studies of Langerhans cells and keratinocytes and T cell subsets in oral lichen planus by anti-T6, anti-HLA-DR, and anti-T3, T4, T8].
    Peng CY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1994 Mar; 29(2):105-7. PubMed ID: 8001425
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of Langerhans' cells in normal and eczematous dermatitis skin by CD1a protein immunohistochemistry: preliminary findings.
    Hussein MR
    J Cutan Pathol; 2008 Jun; 35(6):554-8. PubMed ID: 18312440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: II. Immunomorphological studies in blood and skin lesions.
    Schmitt D; Thivolet J
    J Clin Immunol; 1982 Jul; 2(3 Suppl):111S-119S. PubMed ID: 6982276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza virus-specific cytotoxic T lymphocytes recognize HLA-molecules. Blocking by monoclonal anti-HLA antibodies.
    McMichael AJ; Parham P; Brodsky FM; Pilch JR
    J Exp Med; 1980 Aug; 152(2 Pt 2):195s-203s. PubMed ID: 6967937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Langerhans' cells in skin tumors.
    Schreiner TU; Lischka G; Schaumburg-Lever G
    Arch Dermatol; 1995 Feb; 131(2):187-90. PubMed ID: 7857116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal Langerhans' cells and their function in the skin immune system.
    Hogan AD; Burks AW
    Ann Allergy Asthma Immunol; 1995 Jul; 75(1):5-10; quiz 10-2. PubMed ID: 7621061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of antigen-presenting cells in the regulation of delayed-type hypersensitivity. II. Epidermal Langerhans' cells and peritoneal exudate macrophages.
    Morikawa Y; Furotani M; Matsuura N; Kakudo K
    Cell Immunol; 1993 Nov; 152(1):200-10. PubMed ID: 8242760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts.
    Nunez G; McPhaul J; Stastny P
    Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cultured human Langerhans' cells are superior to fresh cells at presenting native HIV-1 protein antigens to specific CD4+ T-cell lines.
    Girolomoni G; Valle MT; Zacchi V; Costa MG; Giannetti A; Manca F
    Immunology; 1996 Feb; 87(2):310-6. PubMed ID: 8698396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR antigen expression in pterygium epithelial cells and lymphocyte subpopulations: an immunohistochemistry study.
    Ioachim-Velogianni E; Tsironi E; Agnantis N; Datseris G; Psilas K
    Ger J Ophthalmol; 1995 Mar; 4(2):123-9. PubMed ID: 7795511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Functional aspects of Langerhans cells in the oral mucosa].
    Gombos F; Serpico R; Femiano F
    Arch Stomatol (Napoli); 1985; 26(2):207-13. PubMed ID: 3879801
    [No Abstract]   [Full Text] [Related]  

  • 17. Lymphoid tissue targeting of anti-HIV drugs using liposomes.
    Désormeaux A; Bergeron MG
    Methods Enzymol; 2005; 391():330-51. PubMed ID: 15721390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells.
    Katayama I; Matsunaga T; Yokozeki H; Nishioka K
    Br J Dermatol; 1997 Jun; 136(6):846-52. PubMed ID: 9217815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells.
    Moulon C; Péguet-Navarro J; Courtellemont P; Redziniak G; Schmitt D
    Immunology; 1993 Nov; 80(3):373-9. PubMed ID: 7507088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood B cells producing donor-specific HLA antibodies in vitro.
    Han M; Rogers JA; Lavingia B; Stastny P
    Hum Immunol; 2009 Jan; 70(1):29-34. PubMed ID: 19026703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.